Clinical Trials Directory

Trials / Terminated

TerminatedNCT02308865

Early Palliative Care in Metastatic Lung Cancer in Northern France

Impact of Early Palliative Care on Quality of Life and Survival of Patients With Non-small-cell Metastatic Lung Cancer in Northern France

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
71 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Single-center, prospective, controlled, open-label, randomized, two parallel arms comparing early Palliative care versus Standard care in patients with non-small-cell metastatic lung cancer

Detailed description

144 patients will be included; 72 per arm. * "Standard" Control arm: patient supported by the onco-respiratory service. * Intervention arm: patients benefit from early palliative care in addition to standard onco-pneumologic care. The main criterion of judgment is the TOI score measured at 12 weeks. FACTL questionnaires, HADS and PHQ-9 will be filled out before randomization , at 12 weeks and 21 weeks

Conditions

Interventions

TypeNameDescription
OTHERmulti disciplinary palliative care monthly consultationsmulti disciplinary palliative care consultations with a doctor, a nurse, a psychologist and posibility of a physical therapist and a worship person.The primary consultation within 3 weeks inclusion and then every month at the same time that consultations onco-respiratory

Timeline

Start date
2014-10-17
Primary completion
2018-02-23
Completion
2018-02-23
First posted
2014-12-04
Last updated
2019-07-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02308865. Inclusion in this directory is not an endorsement.